Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.62B |
| 2 |
Apple
AAPL
|
+$747M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$655M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$427M |
| 5 |
Walt Disney
DIS
|
+$341M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$2.63B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 3 |
Yum! Brands
YUM
|
+$734M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$558M |
| 5 |
Visa
V
|
+$398M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.59% |
| 2 | Technology | 8.45% |
| 3 | Healthcare | 7.6% |
| 4 | Consumer Discretionary | 6.86% |
| 5 | Energy | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4501
CALL
Vanguard Morningstar Growth ETF
VUG
$230B
| $596K | ﹤0.01% |
33,600
+15,600
| +87% | +$261K |
|
4502
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.45B
| $595K | ﹤0.01% |
+5,639
| New | +$588K |
|
|
FOLD
4503
PUT
DELISTED
Amicus Therapeutics
FOLD
| $595K | ﹤0.01% |
70,400
+39,600
| +129% | +$280K |
|
|
GGP
4504
CALL
DELISTED
GGP Inc.
GGP
| $595K | ﹤0.01% |
+20,000
| New | +$550K |
|
4505
FirstCash
FCFS
$8.94B
| $594K | ﹤0.01% |
12,896
+875
| +7% | +$35.3K |
|
4506
Xencor
XNCR
$1.45B
| $593K | ﹤0.01% |
44,155
+11,153
| +34% | +$132K |
|
4507
Ribbon Communications
RBBN
$379M
| $592K | ﹤0.01% |
78,726
-14,551
| -16% | -$97.2K |
|
|
EPIQ
4508
DELISTED
EPIQ SYSTEMS INC
EPIQ
| $592K | ﹤0.01% |
39,413
+731
| +2% | +$9.38K |
|
4509
Amphastar Pharmaceuticals
AMPH
$870M
| $591K | ﹤0.01% |
49,290
+11,711
| +31% | +$138K |
|
4510
CALL
KeyCorp
KEY
$24.3B
| $591K | ﹤0.01% |
53,500
-7,100
| -12% | -$79.3K |
|
|
KCG
4511
PUT
DELISTED
KCG Holdings, Inc.
KCG
| $590K | ﹤0.01% |
49,400
+5,000
| +11% | +$55.5K |
|
4512
CALL
IMAX
IMAX
$2.75B
| $588K | ﹤0.01% |
18,900
+10,300
| +120% | +$315K |
|
4513
PUT
El Pollo Loco
LOCO
$499M
| $588K | ﹤0.01% |
44,100
-3,200
| -7% | -$40.3K |
|
4514
Invesco S&P 500 Revenue ETF
RWL
$9.81B
| $587K | ﹤0.01% |
14,577
| – | – |
|
|
JUNO
4515
CALL
DELISTED
Juno Therapeutics, Inc.
JUNO
| $587K | ﹤0.01% |
15,400
+5,100
| +50% | +$178K |
|
4516
PUT
Centene
CNC
$31.7B
| $585K | ﹤0.01% |
19,000
-49,800
| -72% | -$1.49M |
|
4517
PUT
Gold Fields
GFI
$33.5B
| $585K | ﹤0.01% |
148,500
+94,200
| +173% | +$352K |
|
4518
Hackett Group
HCKT
$277M
| $585K | ﹤0.01% |
+38,712
| New | +$553K |
|
4519
Main Street Capital
MAIN
$5.31B
| $585K | ﹤0.01% |
18,676
-18,854
| -50% | -$548K |
|
4520
WisdomTree US Total Dividend Fund
DTD
$1.68B
| $584K | ﹤0.01% |
15,724
-15,314
| -49% | -$535K |
|
4521
CALL
NovaGold Resources
NG
$3.02B
| $584K | ﹤0.01% |
115,900
+17,700
| +18% | +$81.5K |
|
|
FLG
4522
PUT
Flagstar Bank National Association
FLG
$5.92B
| $584K | ﹤0.01% |
12,233
+1,800
| +17% | +$83.4K |
|
4523
1st Source
SRCE
$2.15B
| $583K | ﹤0.01% |
18,309
-17,682
| -49% | -$537K |
|
4524
Pacific Biosciences
PACB
$363M
| $580K | ﹤0.01% |
68,287
-111,469
| -62% | -$1.1M |
|
|
CBF
4525
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $579K | ﹤0.01% |
18,756
-4,714
| -20% | -$141K |
|
Similar funds
Goldman Sachs's Q1 2016 Portfolio in Review
As of Q1 2016, Goldman Sachs held 7,717 positions worth $304B, down 4.6% from $319B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $11.3B in Q1 2016, closing 656 positions and reducing 3,244 holdings. Its most notable exit was CHUBB CORPORATION, an estimated $383M position sold in full.
By sector, the portfolio is most concentrated in Financials at 8.6% of assets, down from 9.2% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Goldman Sachs opened a new position in Welbilt, Inc. worth $36.5M.
- Goldman Sachs's largest Q1 2016 buy was Welbilt, Inc.: 2,476,061 shares worth $36.5M.
- Goldman Sachs added most to Pfizer in Q1 2016, an estimated $1.62B increase.
- Goldman Sachs's biggest Q1 2016 reduction was Zimmer Biomet, cutting an estimated $2.63B.
- Goldman Sachs fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $383M.
- Goldman Sachs's ten largest holdings make up 15% of its $304B portfolio in Q1 2016.
- Goldman Sachs opened 593 new positions and closed 656 in Q1 2016.
- Goldman Sachs's portfolio value fell 4.6% quarter-over-quarter to $304B.
Based on Goldman Sachs's 13F filing for Q1 2016, filed 13 May 2016.